A Weekly Health Policy Round Up From Health Affairs
 
 
 
 
A Weekly Health Policy Round Up From Health Affairs            

July 28, 2019
HEALTH AFFAIRS EVENTS

HEALTH SPENDING:  MOVING FROM THEORY TO ACTION

Wednesday, September 11, 2019
9:00 am – 3:00 pm Eastern
National Press Club – Washington, DC
REGISTRATION NOW OPEN

Eighteen months ago, Health Affairs teamed with the National Pharmaceutical Council and Anthem, Inc. to launch a multi-year project to promote an evidence-based conversation about health spending. To continue the discussion, Health Affairs and the National Pharmaceutical Council are hosting a forum that will address:

  • The pressures presented by soaring health costs on individuals, employers, and government
  • Strategies among payers and others to promote cost effective care
  • Efforts currently underway to bring costs under control

Speakers include:

  • Mandy Cohen, Secretary, North Carolina Department of Health and Human Services
  • Patrick Conway, President and CEO, Blue Cross and Blue Shield of North Carolina
  • Robert W. Dubois, Executive Vice President and Chief Science Officer, National Pharmaceutical Council
  • Christopher F. Koller, President, Milbank Memorial Fund
  • Reed Tuckson, Managing Director, Tuckson Health Connections, LLC
  • Alan Weil, Editor-in-Chief, Health Affairs

Be part of the conversation on September 11.
                                    
Get event-specific emails delivered directly to your inbox.

THIS WEEK ON THE BLOG

HEALTH REFORM

Could States Do Single-Payer Health Care?
By Erin C. Fuse Brown  Elizabeth Y. McCuskey

The time has come to remove ERISA’s obstructions and to unlock states’ capacities as laboratories of health reform. Read More >>

PHARMACEUTICALS & MEDICAL TECHNOLOGY

Senate Hearings On Drug Prices: Many Questions, Few (Useful) Answers
By Inmaculada Hernandez and Walid F. Gellad

Given the opacity of the pharmaceutical system, the most valuable part of congressional hearings on drug prices is arguably the collection of information that is otherwise invisible to public discussion. Read more >>


To Fulfill Their Mission, Health Care Facilities Should Better Accommodate Cannabis Patients
By Shereef M. Elnahal and Jeff Brown

Medicinal marijuana is becoming an ever more common remedy among patients and physicians alike. Read more >>

It’s Time To Limit Drug Price Increases
By Gerard Anderson

Since a price inflation penalty would apply to all drugs covered under Medicare Part D, the incentive would be the same for all companies: keep price hikes below the allowable rate of increase in the list price. Read more >>

Orphan Drugs For Opioid Use Disorder: An Abuse Of The Orphan Drug Act
By Kao-Ping Chua and Rena M. Conti

The FDA should require that criteria for orphan designation are still met each time a drug is approved under a previously granted designation. Read More >>

Understanding The Senate Finance Committee’s Drug Pricing Package
By Rachel Sachs

In this post, I first summarize key provisions from the package, explaining how it aims to lower prescription drug prices. Next, I situate the Committee’s package within the broader set of drug pricing reforms being considered by the federal government. Finally, I explain the key objections levied by Senators during Thursday’s markup and how those objections might affect the development of the package going forward. Read more >>


FOLLOWING THE ACA

ACA Round-Up: Delaware’s 1332 Application, Cadillac Tax Repeal, and More
By Katie Keith

This post discusses Delaware’s new application for a state-based reinsurance program, the House’s bipartisan repeal of the Cadillac tax, recent guidance on health savings accounts pursuant to President Trump’s recent executive order, and other guidance issued by the Internal Revenue Services (IRS) and Centers for Medicare and Medicaid Services (CMS). Read more >>


ETHICS

Remembering Daniel Callahan, A Pioneer Of Bioethics
By Arthur Caplan

Daniel Callahan, who pioneered the field of bioethics, died July 17th, two days before his 89th birthday. Dan’s mentoring tree seems to involve half the people doing bioethics today.  No one played a bigger role in my career than Dan. Read More >>


MEDICAID

The Problematic Law And Policy Of Medicaid Block Grants
By Rachel Sachs and Nicole Huberfeld

Capped spending would very likely involve disenrollment and other cost-cutting measures that endanger the lives of the most vulnerable patients. Read More >>

ACCESS TO CARE

Forging A Realistic Path To Universal Coverage
By Jack Meyer

Instead of repealing the ACA or forcing people out of private coverage, we can construct a mixed public/private approach using large building blocks to forge a solid structure. Read More >>


CONSIDERING HEALTH SPENDING

Revisiting The Internal Revenue Service’s Eligible Medical And Dental Expenses
By Laura C. Myers, David W. Bates, and Bonnie B. Blanchfield

We believe that Publication 502 can be clarified and improved by allowing for the deduction of expenses related to disease prevention, incentivizing healthy eating and exercise behaviors, and providing clear, religiously neutral guidance about what qualifies as a medical or dental expense. Read more >>


ELSEWHERE@HEALTH AFFAIRS

From The Archives: Health Spending
By Rachel Dolan

While this post is by no means a comprehensive review of all of the health spending literature, it attempts to at least skim the surface of everything that’s been covered in the pages of Health Affairs (plus a few other sources). Read more >>

GRANTWATCH

Lessons In Philanthropy: Three Decades Of Improving Health In Kansas

By Steve Coen

The leader of the Kansas Health Foundation (since 2008) reflects on his 31 years of working at the statewide foundation and looks to retirement. For example, he says, the foundation saw a need for health data and for leadership skill-building in the state, and so the KHF created the nonprofit Kansas Health Institute, which focuses on health policy, and the Kansas Leadership Center.
Read more >>

IN THE JOURNAL

CONSIDERING HEALTH SPENDING

The Impact of Price Regulation On The Availability of New Drugs In Germany
By Ariel D. Stern, Felicitas Pietrulla, Annika Herr, Aaron S. Kesselheim, and Ameet Sarpatwari

Ariel Stern and coauthors study how Germany’s regulatory regime, adopted in 2011, affects the availability of new drugs. Read More >>


Listen to the Newsmakers Podcast.


GLOBAL HEALTH POLICY

Epidemiological And Health Systems Implications Of Evolving HIV And Hypertension In South Africa And Kenya
By Brianna Osetinsky, Jan A. C. Hontelez, Mark N. Lurie, Stephen T. McGarvey, Gerald S. Bloomfield, Sonak D. Pastakia, Richard Wamai, Till Bärnighausen, Sake J. de Vlas, and Omar Galárraga

Brianna Osetinsky and coauthors analyze changing disease demographics in regions of South Africa and Kenya. Read More >>


MEDICAID

By Nam Hyo Kim, Kevin A. Look, and Marguerite E. Burns

Nam Hyo Kim and coauthors analyze administrative drug claims data to evaluate changes in the use of and out-of-pocket spending on antidiabetic drugs among childless adults who experienced the drug coverage expansion. Read more >>


AFFORDABLE CARE ACT

By Sumit D. Agarwal, Anna L. Goldman, and Benjamin D. Sommers

Sumit Agarwal and coauthors analyze national survey data and find that workers in traditionally blue-collar industries experienced the largest gains in health insurance after implementation of the Affordable Care Act (ACA) in 2014.
Read More >>


NURSING HOMES

By Jennifer Gaudet Hefele, Xiao "Joyce" Wang, and Emily Lim

Jennifer Hefele and coauthors report findings for the first round of incentives and penalties under the Medicare Skilled Nursing Facility Value-Based Purchasing Program. Read more >>

Call For Submissions: Narrative Matters Poetry Contest 2019

The Narrative Matters section of Health Affairs is seeking poetry submissions for an upcoming issue of the journal.

We are holding a poetry contest, from July 1 to August 31, looking for well-crafted poems that touch on topics related to health and health policy. Three winning poems will be announced in September. Winning poets will receive a monetary prize—$500 for first place, $300 for second, and $100 for third—as well as publication in Health Affairs, and two copies of the issue containing the winning poem.

All entries will be read and judged by Health Affairs staff.


  • Limit 3 poems submitted per person. Each poem—in pdf or word doc format—should be submitted as a separate entry through our submission portal here.
  • Poems must be no longer than a single-spaced page, with double spaces between stanzas
  • Font size no smaller than 11 point.
  • Poems must be written in English.
  • Poems must be previously unpublished.
  • Poems themselves should contain no personal identifiers.

You can read some earlier poems published by Health Affairs, including the winners of the 2015 Narrative Matters poetry contest, poems by patients and consumers, poems on vulnerable populations, and poems on the cancer experience.

We look forward to reading your submissions!

 
 
 
 
About Health Affairs

Health Affairs is the leading peer-reviewed journal at the intersection of health, health care, and policy. Published monthly by Project HOPE, the journal is available in print and online. Late-breaking content is also found through healthaffairs.org, Health Affairs Today, and Health Affairs Sunday Update.  

Project HOPE is a global health and humanitarian relief organization that places power in the hands of local health care workers to save lives across the globe. Project HOPE has published Health Affairs since 1981.

Copyright © Project HOPE: The People-to-People Health Foundation, Inc.
Health Affairs, 7500 Old Georgetown Road, Suite 600, Bethesda, MD 20814, United States

Privacy Policy

To update your email preferences or to unsubscribe from this email, click here.